Update to an open-label clinical trial of vismodegib as neoadjuvant before surgery for high-risk basal cell carcinoma (BCC) Journal of the American Academy of Dermatology Kwon, G. P., Ally, M., Bailey-Healy, I., Oro, A. E., Kim, J., Chang, A. S., Aasi, S., Tang, J. Y. 2016; 75 (1): 213-15